Search | Sort | Filter
When launching a startup in Italy, it is critical to comply with the applicable data...
We discuss strategies to navigate shareholder disputes, from understanding unfair...
This update on open data licenses discusses the basics, highlights common license types...
OLNS#12 explains the role, duties, and best practices of advisory boards in German...
Venture Funding and Tech Trends in AI in Drug Discovery
Find out how the market is shifting, from regulatory changes to new investment priorities.
Tony Chan and David Schulman discuss a new transaction structure involving mergers...
COVA will combine with ECARX and be publicly listed on Nasdaq as “ECX”.
Learn about the expertise and value that bankers bring to the sale process.
In the seventh instalment of Orrick's Founder Series, our Cyber, Privacy & Data...
In part one of a two-part series, we explain the key issues and complexities that UK...
As the year draws to a close, we welcome Peter Renton for a conversation about...
In Deal Flow's fifth anniversary edition, we’re sharing insights on investment terms and...
Jim Rabuck of the Defense Innovation Unit sat down with Montana Ware to discuss how the...
Evolving Antitrust Scrutiny of Life Sciences M&A—What's in the Pipeline?
The ICO has issued a draft guidance on using biometric data and technologies. This is...
ESG factors are increasingly important in the life sciences. Managing ESG risks and...
The EU AI Act, which is progressing towards adoption by the end of 2023, will be...
Learn more about Italy’s venture tech activity in 2024 and the talent opportunities in...